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Abstract
Glucuronidation by the UDP-glucuronosyltransferase enzymes (UGTs) is one of the primary
detoxification pathways of dietary heterocyclic amines (HCAs) and polycyclic aromatic
hydrocarbons (PAHs). In a population-based case-control study of 537 cases and 866 controls, we
investigated whether colon cancer was associated with genetic variations in UGT1A1 and UGT1A9
genes and we determined if those variations modify the association between colon cancer and dietary
HCA and PAH exposure. We measured functional UGT1A1 polymorphisms at positions −53 (*28;
A(TA)6TAA to A(TA)7TAA), −3156 (G>A), −3279 (T>G) and the UGT1A9-275(T>A)
polymorphism, and found no association with colon cancer overall. However, when stratified by
race, the UGT1A1-3279 GG/TG intermediate/low activity genotypes were associated with an
increased risk of colon cancer (odds ratio (OR) = 1.5, 95% confidence interval (CI)=1.1–2.0) in
Caucasians. This finding is also supported by haplotype analyses where the UGT1A1-3279G-allele-
bearing haplotype is overrepresented in case group. Overall, UGT1A1-53 and -3156 genotypes
modified the association between dietary benzo(a)pyrene (BaP) and colon cancer (P for
interaction=0.02 and 0.03, respectively). The strongest association was observed for those with <7.7
ng/day BaP exposure and the low activity genotypes, for both UGT1A1*28/*28 (OR=1.8, 95%
CI=1.1–2.9) and −3156AA (OR=1.7, 95% CI=1.0–3.0), compared to ≥7.7 ng/day and combined
high/intermediate genotypes. These data support a hypothesis that UGTs modify the association
between meat-derived PAH exposure and colon cancer by their role in the elimination of dietary
carcinogens.
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Consumption of red meat is associated with an increased risk of colorectal cancer (CRC) [1,
2]. Cooking of red meat using high temperature cooking methods produces several mutagens,
including heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) [3,4].
As demonstrated by the Ames test, those molecules are potent mutagens and have carcinogenic
properties in animal models (reviewed by Turesky [5]). While such environmental factors
could have a great influence on cancer susceptibility, approximately 35% of the risk of colon
cancer is attributable to heritable factors [6]. Thus, variation in genes involved in the
metabolism of HCAs and PAHs could influence risk of cancer via the exposure to these
carcinogenic molecules.
Once consumed, HCAs are bioactivated by cytochrome P450s into N-hydroxy-HCAs and then
esterified by N-acetyltransferases (NATs) or sulfotransferases (SULTs) thus potentializing
their carcinogenic properties through the formation of DNA-adducts by the esterified HCAs
[7,8]. However, the genotoxic potential of N-hydroxy molecules is also influenced by phase
II enzymes, namely UDP-glucuronosyltransferases (UGTs) [9].
Several case-control studies investigated the role of UGT polymorphisms on susceptibility to
CRC. The most common finding showed that the presence of variant in UGT1A7, particularly
the UGT1A7*3 allele, is associated with an increased risk of colorectal cancer or adenoma
[10–12]. In addition, the influence of the UGT1A1*28 allele was also investigated in two of
these studies but did not revealed any significant association with CRC [11,12], while carriers
of the mutant allele for UGT1A1 G71R polymorphism, frequently found in the Asian
population, have an increase risk of CRC [11]. Two case-control studies showed no association
between CRC and UGT1A6 variants T181A and R184S [13,14]. Finally, using a food
frequency questionnaire developed by Sinha et al. [15,16], we have previously reported
modification by NAT1 and UGT1A7 genotypes on the association with meat and meat-derived
HCA exposure in a population-based case-control study of colon cancer [17,18].
Other individual UGT enzymes may have a more important role in detoxification of food-borne
carcinogens. For instance, UGT1A1 is the main hepatic enzyme responsible for the in vitro
glucuronidation of N-OH-PhIP, the most abundant HCA found in cooked meat [19,20].
Moreover, the formation of N-OH-PHIP-N2-G and N3-G in human liver microsomes is strongly
correlated with UGT1A1 expression. The promoter polymorphisms at positions -3279(T>G),
-3156(G>A) and -53 (presence of 7 TA repeats in the UGT1A1 promoter; UGT1A1*28)
reducing UGT1A1 protein expression, have been correlated with lower levels of formation of
N2-G and N3-G metabolites in human liver microsomes [19]. Additionally, UGT1A9 is one of
the most active UGT towards the hydroxy metabolites of BaP, namely 3-OH-BaP, 7-OH-BaP
and 9-OH-BaP [21,22] and it also has the capacity to conjugate N-OH-PhIP particularly at the
N3-position [19,23]. This suggests that any genetic alterations reducing UGT1A9 activity or
expression could influence the elimination of HCAs or PAHs. For instance, previous studies
showed that the UGT1A9-275 AT genotype is associated in vitro with a higher level of
UGT1A9 expression and this is translated in vivo by a reduced exposure to the
immunosuppressive drug MPA [24,25].
These data suggest that genetic alterations in the UGT1 gene could modify the metabolism of
certain carcinogenic compounds and may partially explain the interindividual variation
observed in HCA and PAH metabolism. In this study, we investigated whether colon cancer
was associated with genetic variations in the UGT1A1 and UGT1A9 genes and we determined
if those variations modify the association between colon cancer and red meat consumption (by
type, cooking methods, and doneness preferences) or dietary carcinogen exposure (HCA and
PAH).
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2. Materials and Methods
2.1 Study Population
Cases and controls of the North Carolina Colon Cancer Study were selected from 33 counties
in North Carolina and frequency matched by race, age, and sex [26]. Study design and sample
characteristics have been previously described [27]. In brief, cases were selected through a
rapid ascertainment system [28] established in conjunction with the North Carolina Central
Cancer Registry. Cases were eligible if they were between 40 and 84 years of age at first primary
diagnosis of invasive adenocarcinoma of the colon and diagnosed between 10/01/96 and
09/30/00. The age range was chosen to include cases less likely to be associated with familial
disease. Controls were randomly selected from North Carolina Division of Motor Vehicle lists
if they were under 65 years of age, or from the Center for Medicare and Medicaid Services list
if they were 65 years or older. Of those who were eligible, 84% of cases and 62% of controls
were interviewed. For the analysis of UGT1A1 and UGT1A9 genotypes, 537 cases and 866
controls were included. The controls comprised 325 African Americans and 541 Caucasians,
and the cases, 227 African-Americans and 310 Caucasians. The study was approved by the
Institutional Review Boards at the University of North Carolina School of Medicine, CHUL
Research Center, Laval University, and by equivalent committees at the collaborating
hospitals.
In this study population, African American controls were younger, less educated, and although
more likely to be never smokers, were also more likely to be long-term current smokers,
compared to white controls. Statistically significant case-control differences were not observed
for demographic or smoking characteristics, regardless of race, with the exception of age
among African Americans [27]. Mean daily energy, total fat, total meat, red meat and the
HCAs, DiMeIQx, MeIQx, and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP)
were greater among cases, compared to controls, regardless of race [27]. Dietary fiber was
inversely associated with colorectal cancer [29], while calcium was only inversely associated
among whites [30]. Although folate intake was not associated with colorectal cancer in this
population [30], an approximate two-fold increase in risk was reported for those with low folate
and the wild-type methylenetetrahydrofolate reductase genotype, regardless of race [31].
2.2 Exposure assessment
Questionnaires were administered in person in the participants’ homes by specially trained
registered nurses. The questionnaire collected information on lifestyle factors, such as physical
activity and tobacco use; medical, family, and work histories; and use of over-the-counter
medications. A 150-item food frequency questionnaire was used to measure usual dietary
intake over the year preceding diagnosis for cases, and over the year before date of selection
for controls [32]. The questionnaire was modified to assess individual exposure to dietary
carcinogens based on a meat cooking and doneness module developed by Sinha et al. [16].
Meat intake frequency data, cooking method, and level of doneness were used to estimate
values of three HCAs (MeIQx, PhIP, and DiMeIQx) and BaP, using Sinha’s exposure index
(described in [16,33]). Details regarding the collection of dietary history and the estimated
HCA and PAH exposure have been previously documented [17,27].
2.3 UGT1A1 and UGT1A9 genotyping
Of the individuals with completed questionnaire data, 88% (93% of cases and 85% of controls)
also agreed to provide a blood sample for DNA analyses. In order to assess the influence of
UGT polymorphisms on colon cancer risk, we first genotyped functional polymorphisms of
the UGT1A1 and UGT1A9 genes in 537 colon cancer cases and 866 control subjects by direct
sequencing or by the GeneScan method. The polymorphisms included in the analysis were
selected because they had previously been associated with a significant alteration of the protein
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level or activity [19,24]. UGT1A1 genotyping at position -53 (5, 6, 7 (UGT1A1*28), 8 or 9
TA repeats) was performed by the previously described GeneScan analysis [34]. The PCR
amplifications were performed with different sets of primers; the forward primers were tagged
with fluorescent markers VIC F39-5’-GTCACGTGACACAGTCAAAC-3’ or FAM F35-5’-
GAGGTTCTGGAAGTACTTTGC-3’ while the reverse primers were as followed R107-5’-
GTTTCTTTTTGCTCCTGCCAGAGGTT-3’ and R108-5’-
GTTTCTTCCGCTCGAGCGGCCATGGCGCCTTTGCTCC-3’. The conditions were: 10
cycles of 94°C for 15 sec, 58°C for 15 sec, 72°C for 30 sec, followed by 25 cycles at 89°C for
15 sec, 58°C for 15 sec and 72°C for 15 sec. An initial denaturation step at 95°C for 3 min and
a final extension at 72°C for 15 min were performed. The three amplification products of
different lengths (268 bp, 290 bp and 123 bp) were diluted and mixed with the GeneScan™
500 LIZ™ Size Standard molecular weight maker in 20 µl. Finally, 1 µl of the mix was
separated on a fragment analysis gel on the ABI Prism 3775 DNA Sequencer and analyzed by
GeneScan 2.1 Analysis software (PE Applied Biosystems). The accuracy of the genotyping
method was verified by sequencing of randomly selected PCR products.
The UGT1A1 PBREM (phenobarbital responsive enhancer module) region was amplified with
primers F652-5’-CTGGGGATAAACATGGGATG-3’ and R653-5’-
CACCACCACTTCTGGAACCT-3’. The PCR conditions were: 35 cycles at 95°C for 30 sec,
55°C for 30 sec and 72°C for 30 sec, with an initial denaturation step for 3 min at 95°C and a
final extension at 72°C for 7 min. The UGT1A1 promoter variations in the PBREM region at
positions -3156 and -3279 (relative to the ATG) were genotyped by automated sequencing
using primer F652.
The UGT1A9-275 variation was genotyped by sequencing as described previously [24].
Briefly, PCR amplification was performed with primers F248-5’-
TTGAGACAGAGTCGTGCTGTTT-3’ and R608-5’-GCAAAGCCACAGGTCAGC-3’ and
PCR products were submitted to automated sequencing with primer F516-5’-
GCATTGCAGAGACACAGG-3’. For quality control purposes, 5% of the samples were
randomly selected for both UGT1A1 and UGT1A9 genotyping. In addition positive and
negative controls were included in each experiment. Only three samples failed the
amplification process and thus were not included in the analysis.
2.4 Haplotypes and Linkage Analyses
Haplotypes for UGT1A1 and UGT1A9 were determined using Phase v2.1 program, and
analysis was performed with either Caucasian (n=851) or African-American subjects (n=552).
Haplotypes of 2 or 3 successive markers were estimated with the expectation-maximization
(EM) algorithm [35] implanted in the cocaphase module of UNPHASE version 2.40 [36].
Considering that EM algorithm has limited precision to estimate haplotype frequencies <1%,
such haplotypes were excluded using the –droprare option. Global and individual (-individual
option) likelihood-ratio p-values were estimated for each analysis. The linkage between
different polymorphisms was determined with the linkage disequilibrium (LD) plotter tool
program found at https://innateimmunity.net/.
2.5 Statistical analysis
UGT1A1 and UGT1A9 genotype and allelic frequencies were calculated among African-
American and Caucasian subjects. Differences in genotype and allelic frequencies between
cases and controls among individual race/ethnic groups were assessed by a chi-square test or
Fisher exact test when the number of subjects was lower than five in one of the groups.
UGT1A1 and UGT1A9 genotypes were categorized in three groups based on the predicted UGT
expression and activity [19,24,34]. UGT1A1-53 genotypes was categorized as follows, based
on the number of TA repeats: predicted high (56 and 66), intermediate (57, 58, 67, 68 and 69)
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and low activity (77, 78 and 77). UGT1A1-3156 and -3279 genotypes were classified as
predicted high (GG and TT), intermediate (GA and TG) and low activity (AA and GG). Finally,
UGT1A9 -275 genotype TT was classified as predicted high activity, TA as intermediate and
AA as low. Departure from Hardy-Weinberg disequilibrium was measured among African-
American and Caucasian controls for each polymorphism with a degree of freedom equal to
the number of alleles - 1.
Meat consumption and dietary HCA exposure data were derived from an adapted food
frequency questionnaire, as previously reported [17,27]. All meat (by cooking methods and
doneness preferences), HCAs (MeIQx, DiMeIQx, and PhIP), and BaP exposure assessments
were dichotomized based on the median values of the control group. Joint effect variables were
created with a common reference group based on the control’s median meat intake or exposure
to carcinogens and on the predicted activity associated with UGT1A1 or UGT1A9 genotypes.
For joint effect variables with UGT1A1 genotypes, high and intermediate genotypes were
combined for UGT1A1-53, -3156, while intermediate and low genotypes were combined for
UGT1A1-3279. The pooling strategy was based on observed associations between UGT1A1
genotypes and colon cancer. We also grouped UGT1A9 intermediate and high activity
genotypes because of the low frequency of UGT1A9-275 AA high activity genotypes and
classified the AA and AT genotypes as high and intermediate based on Girard et al [24].
Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for colon cancer were
calculated from unconditional logistic regression models [37]. PROC LOGISTIC of the
software package SAS (version 9.1; SAS Institute, Cary, NC) was used with the option in the
MODEL statement to incorporate offsets, which takes into account the selection probabilities
by age, race, and sex [26]. Multivariable gene effect models included the following variables
to adjust for potential confounding factors: race (African Americans and Caucasians), 5-year
age groups (≤ 45, 46–50, […], ≥ 76 years), and sex. Multivariable joint effect models were
adjusted for race, age, and sex, in addition to dietary fiber, energy adjusted fat intake and total
energy intake. These potential confounding variables were determined previously [17].
As described above, indicator variables were created to estimate the joint effect of dietary
exposure and UGT1A1 or UGT1A9 polymorphisms. Individuals with the lowest hypothesized
associations, less than the median daily intake, and predicted low risk genotypes comprised
the common reference group (OR00). The following ORs were used to assess the expected joint
effect for multiplicative interaction (OR10 X OR01 > OR11), where OR10 was for high intake
and an expected low risk genotype, OR01 was for low intake and an expected high-risk
genotype, and OR11 was for their combined effects. The multiplicative interactions between
the meat intake and the genotypes were evaluated using a likelihood ratio (LR) test where
p<0.05 was considered statistically significant.
3. Results
The allele and genotype frequencies for functional polymorphisms of the UGT1A1 and
UGT1A9 genes are presented in the Table 1. Genotype and allelic frequencies for
UGT1A1-3279 were not significantly different (p>0.05) between Caucasians and African
Americans. In addition, the UGT1A9-275A allele frequency is twice as high in African-
American sample (0.18 vs. 0.07 in Caucasians). None of the typed polymorphisms deviated
from Hardy-Weinberg equilibrium in control group. The most common allele for the
UGT1A1 polymorphism at position -53 (TATA box region of the promoter), was the six TA
repeats (UGT1A1*1). We also observed polymorphic alleles with five (UGT1A1*36), seven
(UGT1A1*28), or eight (UGT1A1*37) TA repeats. A novel allele including six and nine TA
repeats was observed in one African-American control. There were no significant differences
in allelic or genotype frequencies between cases and controls for any polymorphisms
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investigated (Table 1). Strong linkage disequilibrium (LD) was observed between
UGT1A1-53 and UGT1A1-3156 in both populations (r2 = 0.86 in Caucasians and 0.64 in
African-Americans) while a low degree of LD was observed between UGT1A9 and
UGT1A1 polymorphisms (r2 < 0.10).
Haplotype analyses for UGT1A1–UGT1A9 were performed within either Caucasians, African-
Americans or combined subjects. A larger variability was observed in haplotype in the African-
Americans population compared to Caucasians (14 different haplotypes generating 48
diplotypes versus 11 haplotypes generating 23 diplotypes). When all subjects were combined
14 different haplotypes and 51 diplotypes were found. We observed an ethnic-specific effect
in haplotype frequency, most notably with frequent haplotypes. Indeed, the most common
haplotype in African-Americans is UGT1A9-275T, UGT1A1-3279G, UGT1A1-3156A and
UGT1A1-53(TA)7 (TGA7; n=293) followed by TTG6 (n=211), whereas the TTG6 haplotype
was the most frequent (n=879) in Caucasians followed by TGA7 (n=486).
SNP-based colorectal cancer study when sample was stratified by race demonstrated a trend
toward an allelic association for the SNP UGT1A1-3279 (p=0.07) in Caucasians (table 1). In
addition, when we performed genotypic analysis under a dominant model, we showed a
significant association (OR=1.5, 95% CI, 1.1–2.0; table 2). More interestingly, this finding is
supported by 2-SNPs and 3-SNPs haplotype analyses where the UGT1A1-3279G-allele-
bearing haplotype is overrepresented in case group (likelihood-ratio p-value=0.0082 G-G and
0.023 G-G-6; table 3). This effect was not observed within African-Americans (cases= 227,
controls= 325), likely because the striking difference in UGT1A1-3279 allele frequency (table
1).
In Table 4, joint effects for UGT1A1-53, UGT1A1-3156, meat intake, and meat-derived
compound exposure on risk of colon cancer. Both genotypes modified the association between
colon cancer risk and BaP exposure (P for interaction = 0.02 and 0.03, respectively). The
strongest associations were observed for those with less than the median intake of BaP and
with low activity genotypes (Table 4). The association between BaP and colon cancer was not
modified by either the UGT1A1-3279 (OR=1.0, 95% CI, 0.7–1.7, P for interaction = 0.2) or
UGT1A9 (OR=0.9, 95% CI, 0.6–1.3, P for interaction=0.2) genotypes. However, we did
observe modification by UGT1A9-275 genotype for pan-fried red meat consumption and colon
cancer (P for interaction=0.04). The strongest association was observed for 9.0 g/day pan-fried
red meat and the high/intermediate genotype, compared to 9.0 g/day pan-fried red meat
(OR=1.7, 95% CI, 1.1–2.4). We did not observe statistically significant departure from the
multiplicative scale for the remaining UGT1A1-3279 or UGT1A9 genotype-meat or meat
compound joint effects. When Caucasians and African Americans were investigated separately
for interaction, we observed odds ratios with similar magnitude, compared to odds ratios among
the entire study, but they were very imprecise, due to small numbers in each cell (data not
shown). Thus, we only presented results combining race/ethnic groups.
4. Discussion
Using a population-based case-control study, we showed that UGT1A1-3279 TG/GG
intermediate/low genotypes were associated with an increased risk of colon cancer, compared
to high genotypes (UGT1A1-3279 TT). We report statistically significant modification by
UGT1A genotypes for dietary carcinogen and colon cancer associations. Specifically, we report
that individuals with UGT1A1-53 (*28/*28) and -3156 (AA) low genotypes and less than
median BaP exposure were at 1.8- and 1.7-fold greater risk of colon cancer, respectively,
compared to those with high/intermediate genotypes with the same BaP exposure. In addition,
carriers of UGT1A9-275 (AA/AT) high/intermediate genotypes and greater than median intake
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of pan-fried red meat were at a 1.7-fold greater risk of colon cancer, compared to those with
less than median intake with the same genotypes.
We report similar UGT1A1 genotype frequencies to what has been observed in other
populations [38,39]. The largest difference we observed for UGT1A1-3279 between
Caucasians and African Americans was for the TT genotype (0.30 and 0.02, respectively).
Similar genotype frequencies were reported by Innocenti et al [38]. In their study, the
UGT1A1-3279 TT genotype frequencies in Caucasians (n=55) was 0.28, and in African
Americans (n=37) it was 0.03. The UGT1A9-275A frequency of 0.07 was within the range
previously reported (0.04 to 0.09) in Caucasians [39,40].
All three UGT1A1 polymorphisms were in strong linkage disequilibrium, where the strongest
LD was observed between UGT1A1-3156 and UGT1A1-53. There was no significant LD
between UGT1A1 and UGT1A9. This is consistent with the results of Innocenti et al., who
reported an r2 value between 0.7 and 0.9 for UGT1A1-53, -3156 and -3279, and r2<0.2 for
UGT1A9-275 and UGT1A1 polymorphisms [40].
Without assuming the food intake effect, the UGT1A1-3279G-allele, under a dominant model,
demonstrated an increase risk to colorectal cancer in Caucasians, and this is supported by
haplotypic analysis. We did not observe any significant association between CRC and
UGT1A1-3279 in African-Americans. However, the UGT1A1-3279G-allele in this subset
sample is more common (0.82), and our sample is not enough powered to detect such a
difference in allele frequency (0.05 in Caucasians). Moreover, the difference in UGT1A1-3279
allele frequency between TT case and control groups would argue for an overrepresentation
of T-allele in cases, contrasting with results from Caucasian subset. Consequently, we may not
assume a role for UGT1A1-3279 in CRC risk, but we hypothesize that it might genetically link
with other most likely functional polymorphisms in the UGT1 locus.
Dietary BaP exposure was positively associated with colon cancer among carriers of
UGT1A1-53 (*28/*28) and -3156 (AA) low activity genotypes, compared to those with
combined high/intermediate genotypes. Interestingly, this modification by UGT1A1 genotypes
resulted in a stronger association for those who had less than median BaP exposure, compared
to the median or greater exposure. Previously, Fang et al., demonstrated that carriers of the
UGT1A1-53 (*28/*28) low activity genotype had a significant reduction of BPD(−)
glucuronidation when UGT1A9 was inhibited in assays with human liver microsomes [41].
Thus, the exact contribution of UGT1A1 to in-vivo glucuronidation of BaP remains to be
elucidated, but our result might indicated that intake of even small amounts of carcinogens
influences the risk of colon cancer and that consequently the median daily intake value might
not constitute the most appropriate classification method for certain meats or carcinogens.
Another possible explanation for a stronger association with less than median BaP exposure
is the idea of “saturation” of the enzyme at higher levels of exposure. For example, it has been
hypothesized that the metabolic genetic effects, such as those with the UGTs, are most relevant
at low to middle level exposures to carcinogenic compounds, such as BaP, rather than at high
levels where the exposure is likely to saturate the enzyme activity and diminish the differences
between UGT1A1 “high/intermediate” and “low” activity [42,43]. We have previously
reported the same antagonism effect for UGT1A7 low-activity genotypes and dietary BaP on
risk of colon cancer in this population [17]. Thus, our findings appear to support a low-dose
joint effects model between UGT1A1, UGT1A7, and dietary BaP on the association with colon
cancer.
We previously found that UGT1A1 polymorphisms were strongly associated with the in-
vitro hepatic glucuronidation of the N-OH-PHIP [19]. However, modification by UGT1A1
genotypes for PhIP and colon cancer was not observed in our data. This result could be
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explained by the interindividual variability observed in the CYP1A2 activity, the enzyme
responsible for the conversion of PhIP to N-OH-PhIP [44]. Because of this variability, it is
possible that the estimation of the PhIP exposure is not a precise measure of the N-OH-PhIP
exposure.
We showed for the first time the impact of UGT1A9-275 polymorphism on colon cancer risk,
the joint effect is observed for pan-fried meat and -275 high/intermediate (AA/AT) activity
genotype (P for interaction=0.04). Meat that is cooked above a heat source, by methods such
as barbecuing, contain the highest levels of PAHs [33], because the meat is exposed to smoke
formed from the pyrolysis of fatty juices that drip down onto the heat source [45]. In contrast,
the optimal conditions for HCA formation include high-temperature cooking such as pan-
frying [46].
The influence of UGT1A9 on cancer risk through pan-fried red meat deserves further
exploration. Pan-fried red meat was associated with a two-fold increase in risk of colon cancer
in this population [27]. We observed the strongest association among the high/intermediate
UGT1A9 genotype, suggesting either poor genotype-phenotype correlation, or that there is
something in pan-fried red meat other than HCAs that are driving the association.
The predicted activity of UGT1A9 genotypes was based on our previous results where we
demonstrated a higher level of UGT1A9 protein in human liver microsomes in subjects
carrying the -275A allele [24]. UGT1A9 is the most efficient enzyme in the formation of N-
OH-PhIP-N3-G [12]. Higher formation of N-OH-PhIP-N3-G associated with the -275A allele
has the potential to increase the exposure of the colon to N3-G, which can be further hydrolyzed
to N-OH-PhIP by bacterial β-glucuronidases and converted locally to reactive metabolites
[47]. However, the -275 polymorphism could have a different impact in other tissues and still
its functional impact on gene transcription in various tissues has not been resolved yet. It could
also be influenced by UGT inducers found in the diet [48,49] and thus UGT1A9 results should
be analyzed cautiously in regard of the classification of the predicted activity. On the other
hand, polymorphisms in the UGT1A1 promoter are well known to reduce UGT1A1 protein
expression [19,34,50], bilirubin [51] and SN-38 glucuronidation [52,53], and consequently
misclassification is less probable.
In this study, we stratified the data by both UGT1 genotype and meat-related dietary factors to
determine their joint effects on the association for colon cancer. Although these statistical
comparisons were based on a priori hypotheses driven by experimental and epidemiologic
evidence, we cannot exclude the possibility that our statistically significant main finding for
BaP was due to change.
Overall, the results of the present study and of Butler et al. [17] support the hypothesis that
UGTs may play a role in carcinogens elimination and, as a result, influence colon cancer risk.
An investigation of UGT expression in normal and malignant tissues revealed that, in normal
large bowel mucosa, UGT proteins are expressed at high levels whereas there is a considerable
down-regulation in low-grade adenomas and no expression in high-grade adenomas and colon
cancer [54]. In addition, UGT proteins are essentially expressed in the luminal cells with which
the carcinogens from the diet come into direct contact. Based on this expression profile,
Giuliani et al. concluded that UGT proteins may participate in the early phase of colon
malignant transformation and could play a role of prevention against carcinogenesis [54]. The
data obtained in the present study are in agreement with this hypothesis; subjects with high
expression of UGT1A1 would eliminate HCAs or PAHs more rapidly and thus could be less
at risk of colon cancer through benzo(a)pyrene exposure. In conclusion, our data point toward
a potential influence of UGT1A1 and UGT1A9 polymorphisms on colon cancer risk through
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meat consumption and PAH exposure and suggest that UGT enzymes have an important role
of elimination for food-borne carcinogens.
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